Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Computational Biology Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The computational biology market has experienced significant expansion in recent years. Its valuation is expected to rise from $9.47 billion in 2025 to $11.68 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 23.4%. Historically, this growth can be ascribed to breakthroughs in genomic sequencing technologies, the increasing accessibility of biological datasets, growing partnerships between biology and computer science, the expansion of academic bioinformatics research, and the early incorporation of computational modeling in life sciences.
The computational biology market is projected to experience rapid expansion over the upcoming years. Its valuation is anticipated to reach $27.32 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.7%. This growth during the projected timeframe stems from factors such as a heightened need for precision medicine solutions, greater capital expenditure in drug discovery analytics, the proliferation of cloud-based bioinformatics platforms, an expanding application of AI-driven biological insights, and an increasing dependence on data-informed clinical research. Key developments expected in this period encompass a rising application of algorithm-powered biological modeling, an uptick in the embrace of in-silico drug discovery instruments, enhanced incorporation of multi-omics data analysis, broader deployment of high-performance computing within biology, and a sharpened emphasis on biological simulations for prediction.
Get A Free Sample Report With In-Depth Market Insights:
Computational Biology Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The rising demand for personalized medicine is projected to drive the growth of computational biology moving forward. Personalized medicine, also referred to as precision medicine, is an approach to medical care and treatment that considers individual differences in genes, environment, and lifestyle when formulating patient treatment plans. This approach relies on examining an individual’s genetic data to customize medical treatments. Computational biology plays a critical role in interpreting this genetic information, enabling the development of targeted therapies, optimizing treatment regimens, and predicting treatment outcomes. It also helps categorize patients into specific subgroups, reduces healthcare costs, and aligns with regulatory and clinical guidelines. For example, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, stated that the FDA approved 16 new personalized treatments for rare disease patients in 2023, which was an increase from six in 2022. Therefore, the increasing demand for personalized medicine is propelling the growth of the computational biology market.
Computational Biology Market Segment Analysis: What Are The Core Market Categories?
The computational biology market covered in this report is segmented –
1) By Services: In-house, Contract
2) By Tools: Databases, Infrastructure (Hardware), Analysis Software and Services
3) By Application: Cellular and Biological Simulation, Drug Discovery and Disease Modelling
4) By End User: Research, Pharmaceutical Industry, Commercial Applications
Subsegments:
1) By In-house: Data Analysis, Software Development, Research And Development
2) By Contract: Outsourced Bioinformatics, Collaborative Research, Data Management Services
Computational Biology Market Innovation Trends Shaping Future Development
Major companies operating in the computational biology market are actively developing new solutions for proteomics research to gain a competitive edge in the market. Proteomics research is a scientific field dedicated to the comprehensive analysis of proteins within a biological system. For instance, in May 2023, Biognosys AG, a biotechnology company based in Switzerland, launched Spectronaut 18, introducing significant scientific and technological enhancements for its specialized proteomics research software and offerings. Spectronaut 18 delivers high throughput and efficiency in data-independent acquisition (DIA) proteomics analysis. The company’s TrueDiscovery platform accelerates biomarker discovery in fields like oncology and neuroscience by providing unparalleled depth and sensitivity in proteomics. TrueTarget enables high-resolution drug target identification and deconvolution, and Biognosys’ iRT Kit, recommended for real-time system suitability monitoring, is now supported in combination with Bruker ProteoScape software.
Computational Biology Market Top Companies Driving Competitive Growth
Major companies operating in the computational biology market are Certara L.P.; Chemical Computing Group Inc.; Compugen Ltd.; Genedata AG; Dassault Systèmes SE; Rosa & Co. LLC; Simulation Plus Inc.; Nimbus Discovery LLC; Rhenovia Pharma SAS; DNAnexus; Genialis Inc.; BC Platforms; Schrodinger Inc.; Strand Life Sciences; Numerate Inc.; Insitro; Recursion Pharmaceuticals; Atomwise; Relay Therapeutics; Exscientia
View The Full Computational Biology Market Report:
Computational Biology Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the computational biology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computational biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
